Krystal Biotech, Inc.
US ˙ NasdaqGS ˙ US5011471027

SecurityKRYS / Krystal Biotech, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership2,726 shares
Latest Disclosed Value $ 704,180
Citadel Advisors Llc ownership in KRYS / Krystal Biotech, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 2,726 shares of Krystal Biotech, Inc. (US:KRYS) valued at $704,180 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 386,505 shares of Krystal Biotech, Inc.. This represents a change in shares of -99.29% during the quarter. The current value of the position is $822,761 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (KRYS) in the form of stock options. The firm currently holds call options representing 18,900 of underlying shares valued at $4,882,248 USD and put options representing 10,500 of underlying shares valued at $2,712,360 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

KRYS / Krystal Biotech, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM 501147102 2,726 -383,779 -99.29 704 -99.26 0.0001
2026-02-17 2025-12-31 13F KRYSTAL BIOTECH COM 501147102 386,505 -250,483 -39.32 95,289 -15.26 0.0143
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM 501147102 636,988 602,428 1,743.14 112,447 2,267.31 0.0171
2025-08-14 2025-06-30 13F KRYSTAL BIOTECH COM 501147102 34,560 34,464 35,900.00 4,751 27,841.18 0.0008
2025-05-15 2025-03-31 13F KRYSTAL BIOTECH COM 501147102 96 -10,919 -99.13 17 -99.01 0.0000
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM 501147102 11,015 10,919 11,373.96 1,726 10,047.06 0.0003
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM 501147102 96 96 17 0.0000
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM 501147102 0 -25,014 -100.00 0 -100.00
2024-05-15 2024-03-31 13F KRYSTAL BIOTECH COM 501147102 25,014 16,815 205.09 4,451 337.56 0.0009
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM 501147102 8,199 3,809 86.77 1,017 99.80 0.0002
2023-11-14 2023-09-30 13F KRYSTAL BIOTECH COM 501147102 4,390 -34,898 -88.83 509 -88.96 0.0001
2023-08-14 2023-06-30 13F KRYSTAL BIOTECH COM 501147102 39,288 -68,037 -63.39 4,612 -46.32 0.0010
2023-05-15 2023-03-31 13F KRYSTAL BIOTECH COM 501147102 107,325 54,649 103.75 8,592 105.94 0.0019
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM 501147102 52,676 43,938 502.84 4,173 585.06 0.0010
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM 501147102 8,738 8,738 609 0.0001
2022-08-15 2022-06-30 13F KRYSTAL BIOTECH COM 501147102 0 -8,732 -100.00 0 -100.00
2022-05-16 2022-03-31 13F KRYSTAL BIOTECH COM 501147102 8,732 -30,013 -77.46 581 -78.56 0.0001
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM 501147102 38,745 7,742 24.97 2,710 67.39 0.0006
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH Cmn 501147102 31,003 31,003 1,619 0.0003
2021-05-21 2021-03-31 13F/A-1 KRYSTAL BIOTECH COM 501147102 0 -28,708 -100.00 0 -100.00
2021-02-16 2020-12-31 13F KRYSTAL BIOTECH COM 501147102 28,708 4,484 18.51 1,723 65.20 0.0004
2020-11-16 2020-09-30 13F KRYSTAL BIOTECH COM 501147102 24,224 2,595 12.00 1,043 16.41 0.0003
2020-08-14 2020-06-30 13F KRYSTAL BIOTECH Cmn 501147102 21,629 -520,073 -96.01 896 -96.17 0.0003
2020-05-15 2020-03-31 13F KRYSTAL BIOTECH Cmn 501147102 541,702 4,855 0.90 23,423 -21.22 0.0105
2020-02-14 2019-12-31 13F KRYSTAL BIOTECH Cmn 501147102 536,847 -1,379 -0.26 29,731 59.07 0.0129
2019-11-14 2019-09-30 13F KRYSTAL BIOTECH Cmn 501147102 538,226 41,056 8.26 18,690 -6.65 0.0088
2019-08-14 2019-06-30 13F KRYSTAL BIOTECH Cmn 501147102 497,170 174,296 53.98 20,021 88.47 0.0092
2019-05-15 2019-03-31 13F KRYSTAL BIOTECH Cmn 501147102 322,874 -12,155 -3.63 10,623 52.61 0.0053
2019-02-14 2018-12-31 13F KRYSTAL BIOTECH Cmn 501147102 335,029 335,029 6,961 0.0038
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM Call 18,900 1.07 4,882 5.90 n/a n/a n/a
2026-02-17 2025-12-31 13F KRYSTAL BIOTECH COM Call 18,700 32.62 4,610 85.21 n/a n/a n/a
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM Call 14,100 -34.42 2,489 -15.77 n/a n/a n/a
2025-08-14 2025-06-30 13F KRYSTAL BIOTECH COM Call 21,500 123.96 2,955 70.81 n/a n/a n/a
2025-05-15 2025-03-31 13F KRYSTAL BIOTECH COM Call 9,600 -60.17 1,731 -54.17 n/a n/a n/a
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM Call 24,100 -47.95 3,776 -55.20 n/a n/a n/a
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM Call 46,300 68.98 8,428 67.50 n/a n/a n/a
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM Call 27,400 -32.01 5,032 -29.83 n/a n/a n/a
2024-05-15 2024-03-31 13F KRYSTAL BIOTECH COM Call 40,300 1.77 7,171 45.97 n/a n/a n/a
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM Call 39,600 145.96 4,913 163.10 n/a n/a n/a
2023-11-14 2023-09-30 13F KRYSTAL BIOTECH COM Call 16,100 62.63 1,868 60.67 n/a n/a n/a
2023-08-14 2023-06-30 13F KRYSTAL BIOTECH COM Call 9,900 -11.61 1,162 29.69 n/a n/a n/a
2023-05-15 2023-03-31 13F KRYSTAL BIOTECH COM Call 11,200 -36.00 897 -35.35 n/a n/a n/a
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM Call 17,500 49.57 1,386 70.06 n/a n/a n/a
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM Call 11,700 -40.00 815 -36.33 n/a n/a n/a
2022-08-15 2022-06-30 13F KRYSTAL BIOTECH COM Call 19,500 78.90 1,280 76.55 n/a n/a n/a
2022-05-16 2022-03-31 13F KRYSTAL BIOTECH COM Call 10,900 -74.59 725 -75.84 n/a n/a n/a
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM Call 42,900 -26.29 3,001 -1.25 n/a n/a n/a
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH Cmn Call 58,200 584.71 3,039 425.78 n/a n/a n/a
2021-08-16 2021-06-30 13F KRYSTAL BIOTECH COM Call 8,500 102.38 578 78.40 n/a n/a n/a
2021-05-21 2021-03-31 13F/A KRYSTAL BIOTECH COM Call 4,200 -52.27 324 -38.64 n/a n/a n/a
2021-05-17 2021-03-31 13F KRYSTAL BIOTECH COM Call 4,200 324 n/a n/a n/a
2021-02-16 2020-12-31 13F KRYSTAL BIOTECH COM Call 8,800 528 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F KRYSTAL BIOTECH COM Put 10,500 156.10 2,712 168.51 n/a n/a n/a
2026-02-17 2025-12-31 13F KRYSTAL BIOTECH COM Put 4,100 -86.38 1,011 -80.99 n/a n/a n/a
2025-11-14 2025-09-30 13F KRYSTAL BIOTECH COM Put 30,100 62.70 5,314 108.93 n/a n/a n/a
2025-08-14 2025-06-30 13F KRYSTAL BIOTECH COM Put 18,500 537.93 2,543 387.16 n/a n/a n/a
2025-05-15 2025-03-31 13F KRYSTAL BIOTECH COM Put 2,900 -77.52 523 -74.16 n/a n/a n/a
2025-02-14 2024-12-31 13F KRYSTAL BIOTECH COM Put 12,900 65.38 2,021 42.35 n/a n/a n/a
2024-11-14 2024-09-30 13F KRYSTAL BIOTECH COM Put 7,800 -7.14 1,420 -7.98 n/a n/a n/a
2024-08-14 2024-06-30 13F KRYSTAL BIOTECH COM Put 8,400 -75.37 1,543 -74.58 n/a n/a n/a
2024-05-15 2024-03-31 13F KRYSTAL BIOTECH COM Put 34,100 104.19 6,067 192.95 n/a n/a n/a
2024-02-14 2023-12-31 13F KRYSTAL BIOTECH COM Put 16,700 6.37 2,072 13.73 n/a n/a n/a
2023-11-14 2023-09-30 13F KRYSTAL BIOTECH COM Put 15,700 -46.78 1,821 -47.42 n/a n/a n/a
2023-08-14 2023-06-30 13F KRYSTAL BIOTECH COM Put 29,500 64.80 3,463 141.66 n/a n/a n/a
2023-05-15 2023-03-31 13F KRYSTAL BIOTECH COM Put 17,900 -30.89 1,433 -30.13 n/a n/a n/a
2023-02-14 2022-12-31 13F KRYSTAL BIOTECH COM Put 25,900 86.33 2,052 111.66 n/a n/a n/a
2022-11-14 2022-09-30 13F KRYSTAL BIOTECH COM Put 13,900 -20.57 969 -15.67 n/a n/a n/a
2022-08-15 2022-06-30 13F KRYSTAL BIOTECH COM Put 17,500 -4.37 1,149 -5.67 n/a n/a n/a
2022-05-16 2022-03-31 13F KRYSTAL BIOTECH COM Put 18,300 -76.42 1,218 -77.56 n/a n/a n/a
2022-02-14 2021-12-31 13F KRYSTAL BIOTECH COM Put 77,600 691.84 5,428 960.16 n/a n/a n/a
2021-11-15 2021-09-30 13F KRYSTAL BIOTECH Cmn Put 9,800 -40.61 512 -54.37 n/a n/a n/a
2021-08-16 2021-06-30 13F KRYSTAL BIOTECH COM Put 16,500 175.00 1,122 142.86 n/a n/a n/a
2021-05-21 2021-03-31 13F/A KRYSTAL BIOTECH COM Put 6,000 462 n/a n/a n/a
2021-05-17 2021-03-31 13F KRYSTAL BIOTECH COM Put 6,000 462 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.